Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiwan Main Orthopaedic Biotechnology is a medical device company specializing in augmented reality (AR) and mixed reality (MR) solutions for surgical navigation and medical education. The company's flagship products, Caduceus and Foresee-X, utilize smart glasses to provide surgeons with real-time, 3D visualization of internal structures, such as bones and vascular systems, directly overlaid on the patient's anatomy. These technologies aim to improve surgical precision, reduce radiation exposure from X-rays, and significantly shorten operation times. Headquartered in Taichung, Taiwan, the company holds multiple patents and has received regulatory clearances including US FDA 510(k) and CE Mark for its innovative surgical systems. Their solutions are designed to be cost-effective and portable, making advanced navigation accessible to a wider range of clinical settings, including ambulatory surgery centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Main Orthopedics.